Search Results 161-170 of 16471 for Pulmonary hypertension
An Outcome Study Assessing A 75 Milligrams (Mg) Dose Of Macitentan To Treat Patients With Pulmonary Arterial Hypertension ... pulmonary arterial hypertension (PAH) ...
A Study Of Oral Levosimendan In Pulmonary Hypertension With Heart Failure With Preserved Left Ventricular Ejection Fraction · More about research at Mayo Clinic.
A Study To Evaluate Whether Or Not Selexipag Is Effective And Safe In Patients With Chronic Thromboembolic Pulmonary Hypertension When The Disease Is Inoperable ...
2024. SubSpec FellowPulmonary Hypertension, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine · 2023. Fellow ...
Advanced lung disease · COPD · Cystic fibrosis · Hepatopulmonary syndrome · Interstitial lung disease · Pulmonary fibrosis · Pulmonary hypertension · Pulmonary valve ...
Mayo Clinic's top-ranked Pulmonary Medicine Division diagnoses and treats more than 65,000 adults and children with lung (pulmonary) and sleep disorders each ...
A Study to Assess Quality of Life with the PAH SYMPACT Questionnaire in the Pulmonary Hypertension Clinic ... pulmonary hypertension clinic. An additional ...
... hypertension to improve our understanding of this disease and its response to pulmonary arterial hypertension targeted therapy and liver transplantation.
... Pulmonary Arterial Hypertension (PAH). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
A Study To Form A Registry Of Sarcoidosis Associated Pulmonary Hypertension (RESAPH) ... pulmonary hypertension. Participation eligibility. Participant ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.